Deficient prostacyclin formation after acute myocardial infarction. 1987

K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013931 Thromboxanes Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. Thromboxane
D015121 6-Ketoprostaglandin F1 alpha The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue. 6-Keto-PGF1 alpha,6-Oxo-PGF1 alpha,6-Oxoprostaglandin F1 alpha,6 Ketoprostaglandin F1 alpha,6 Keto PGF1 alpha,6 Oxo PGF1 alpha,6 Oxoprostaglandin F1 alpha,F1 alpha, 6-Ketoprostaglandin,F1 alpha, 6-Oxoprostaglandin,alpha, 6-Keto-PGF1,alpha, 6-Ketoprostaglandin F1,alpha, 6-Oxo-PGF1,alpha, 6-Oxoprostaglandin F1

Related Publications

K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson
July 1987, Lancet (London, England),
K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson
June 1985, The American journal of cardiology,
K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson
December 2012, Heart (British Cardiac Society),
K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson
December 1984, Lancet (London, England),
K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson
February 1985, British heart journal,
K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson
November 1986, British heart journal,
K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson
February 1988, The American journal of cardiology,
K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson
December 1981, Thrombosis and haemostasis,
K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson
March 1993, International journal of cardiology,
K Gréen, and O Vesterqvist, and G Rasmanis, and O Edhag, and P Henriksson
April 1983, The New England journal of medicine,
Copied contents to your clipboard!